Soligenix logo

Soligenix

Soligenix is a Princeton, New Jersey-based developer of biodefense vaccines and therapeutics for the side-effects of cancer treatment and gastrointestinal diseases.

2

Funding Rounds

$6.7m

Money raised

Overview

Soligenix is a Princeton, New Jersey-based developer of biodefense vaccines and therapeutics for the side-effects of cancer treatment and gastrointestinal diseases.

Funding

Funding series

Funding Series Analysis

The company Soligenix has raised a total of $6.66m in funding over 2 rounds.

Key Insights:

  • Soligenix seed round: $1.5m
  • Soligenix funding round, June 2010: $5.16m
Soligenix logo
Soligenix seed round $1.5m
Soligenix logo
Soligenix funding round, June 2010 $5.16m

Industries

Soligenix is active in the following industries:
  • Biopharmaceutical
  • Engineering
  • Biosecurity
  • Pharmaceutical industry
  • Therapeutics
  • Biomedical engineering
  • Technology
  • Healthcare
  • Biology
  • Biotechnology